Xudong Haipu Pharmaceutical

Shanghai Xudong Haipu Pharmaceutical Co., Ltd. was established in January 1993 as a pharmaceutical enterprise jointly invested by Taiwan TTY Biopharm International Co., Ltd. and the then Shanghai Haipu Pharmaceutical Factory. Shanghai Haipu Pharmaceutical Factory, a specialized injection manufacturer in China, was founded in 1925 and has developed for over 90 years, accumulating rich production experience and enjoying a good brand reputation within the industry.
The company possesses a full industry chain capability from raw materials to formulations, covering R&D, manufacturing, and marketing. It holds production approvals for nearly a hundred drugs across more than ten major categories, including critical care, cardiovascular, and respiratory diseases. It has dedicated production lines for anti-tumor drugs, hormones, biological products, contrast agents, sustained/controlled-release formulations, and emergency medications.
Adhering to a differentiated competition development strategy and maintaining an annual growth rate of over 30%, the company adjusts its formulation product structure and focuses on becoming a branded company in cardiovascular emergency critical care and respiratory diseases. In quality management and manufacturing, it is transforming towards international standards, striving to become a pharmaceutical enterprise of international quality.